Journal Article

Neutrophil Heterogeneity in Cancer: From Biology to Therapies

Pereira Abrantes, Manuela, Michallet, Marie-Cécile, Lecot, Pacôme, Koenderman, Leo, Mussard, Julie, Caux, Christophe, Bendriss-Vermare, Nathalie, Sarabi, Matthieu

2019

Overview

Neutrophils have been extensively described in the pathophysiology of autoimmune and infectious diseases. Accumulating evidence also suggests the important role of neutrophils in cancer progression through their interaction with cancer and immune cells in blood and in the tumor microenvironment (TME). Most studies have described neutrophils as key drivers of cancer progression, due to their involvement in various tumor promoting functions including proliferation, aggressiveness, and dissemination, as well as in immune suppression. However, such studies were focusing on late-stages of tumorigenesis, in which chronic inflammation had already developed. The role of tumor-associated neutrophils (TANs) at early stages of tumor development remains poorly described, though recent findings indicate that early-stage TANs may display anti-tumor properties. Beyond their role at tumor site, evidence supported by NLR retrospective studies and functional analyses suggest that blood neutrophils could also actively contribute to tumorigenesis. Hence, it appears that the phenotype and functions of neutrophils vary greatly during tumor progression, highlighting their heterogeneity. The origin of pro- or anti-tumor neutrophils is generally believed to arise following a change in cell state, from resting to activated. Moreover, the fate of neutrophils may also involve distinct differentiation programs yielding various subsets of pro or anti-tumor neutrophils. In this review, we will discuss the current knowledge on neutrophils heterogeneity across different tissues and their impact on tumorigenesis, as well as neutrophil-based therapeutic strategies that have shown promising results in pre-clinical studies, paving the way for the design of neutrophil-based next generation immunotherapy.

• Publisher: Frontiers Media SA,Frontiers,Frontiers Media S.A
• Subject: Biomarkers / Blood / Bone marrow / Breast cancer / Cancer / Cancer therapies / Cell growth / Chemotherapy / Colorectal cancer / G-MDSC (granulocytic MDSC) / Immunology / Immunotherapy / Infectious diseases / Innate immunity / Kidney cancer / Leukocytes (neutrophilic) / Life Sciences / Liver cancer / MDSC (myeloid-derived suppressor cells) / Medical prognosis / Metastasis / Mortality / neutrophil (PMN) / Neutrophils / Pathophysiology / Patients / Phenotypes / Prostate / Response rates / Tumor microenvironment / tumor-associated neutrophils (TANs) / Tumorigenesis / Tumors